MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognition in Huntington’s Disease

A. Sethi, O. Kaczmarek, S. Baek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

Meeting: 2022 International Congress

Abstract Number: 652

Keywords: Cognitive dysfunction

Category: Huntington's Disease

Objective: Explore the cognitive profile of patients with Huntington’s Disease (HD) using a digital cognitive battery

Background: Huntington’s Disease (HD) is a relentlessly progressive neurodegenerative disorder typically characterized by cognitive, psychiatric, oculomotor, chorea and gait abnormalities.  Traditional measures of disease impact and change rely on history, neurological examination and incorporation of the United Huntington’s Disease Rating Scale (UHDRS). Incorporating examiner independent objective multi-dimensional quantitative measures of people with HD (PwHD) performance as they relate to patient perception might enhance appreciation of real world value of disease impact along a continuum. This approach might provide unique insight to proactively identify opportunities to both improve outcomes and intervene to reduce adverse outcomes that might not be readily appreciated by clinical examination. The impact of varied degrees and combinations of cognitive impairment in PwHD as they relate to quality of life may not be easily identified in routine care but earlier identification of such impact might provide an opportunity to reduce adverse outcomes.

Method: Retrospective review of data collected through routine care of PwHD that were evaluated by multidimensional computerized cognitive testing. Cognitive domains collected were: Memory (MEM), Executive Function (EF), Visual Spatial (VS), Information Processing (IP), Verbal Function (VF), Attention (ATT), Motor Skills (MS), and a Global Cognitive Summary Score (GCS).

Results: 34 PwHD, average age 50+/- 12. The mean scores by each cognitive domain are: GCS = 74.3, MEM= 70.1, EF = 73.6, VS = 89.0, IP = 87.0, VF = 71.2, ATT = 67.4, and MS = 78.3. 73.5% of the PwHD tested as cognitively impaired in the aggregate global score. The average number of cognitive domains impaired was found to be 3.44.

Conclusion: Physical symptoms of HD are widely discussed and recognized. According to our analysis, the cognitive impact of Huntington’s Disease is apparent and severe as well. According to the objective computerized cognitive battery, PwHD on average have over 3 domains of cognition impaired. Factoring in this impairment is crucial to bettering patient care.

To cite this abstract in AMA style:

A. Sethi, O. Kaczmarek, S. Baek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt. Cognition in Huntington’s Disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/cognition-in-huntingtons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognition-in-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley